作者: Mark A. Rosenthal , Michael L. Gruber , Jon Glass , Anita Nirenberg , Jonathan Finlay
关键词:
摘要: Taxol has activity in the treatment of high grade gliomas but estramustine phosphate (EMP) not been used this setting. In vitro data demonstrates that EMP is cytotoxic to glioma cell lines and binding proteins are expressed by cells. The combination reported be active hormone-refractory prostate cancer taxane-resistant breast ovarian cancer. We therefore performed a phase II study assess toxicity gliomas. was given at dose 225 mg/m2 intravenously over three hours on day 1 900 orally days through 3. Cycles were repeated every weeks. Twenty patients with recurrent glioblastoma multiforme (GBM) enrolled: 11 male, median age 45 years. All received anti-epileptic medications 17 (80%) had prior chemotherapy. Of 18 evaluable patients, two partial responses (11) six stable disease (33%) for minimum eight Treatment well tolerated 3 neutropenia occurring only patients. There no other or 4 toxicities. time progression cohort weeks (range 3-60+ weeks). overall survival 12 conclusion, modest GBM.